PharmaBoardroom

Megalabs: Playing Among Giants in LatAm

The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by familiar big pharma players. However,…

Top 15 Pharma Companies in Central America & Caribbean

The Top 15 pharma companies in the Central America & Caribbean (CENCA) region's retail market (Rx & OTC) for 2019 ranked by sales in USD…

Navigating the Increasingly Stormy Waters of US Market Access

Certara's Ulrich Neumann examines some of the major US market access trends of the past few years, including the innovative financing models required…

Chris Martin – CEO, Co-Founder and Director, ADC…

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey…

Giorgio Calderari – Chairman, Farma Industria Ticino (FIT),…

Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical industries in the Swiss canton of Ticino,…

Vincent Ruland – Country Division Head, Bayer…

Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the company’s priorities in Malaysia,…

Steve Profit – General Manager, Novo Nordisk Taiwan

Novo Nordisk's Steve Profit outlines the progression of the group's strategy in Taiwan, how the affiliate works with the Taiwanese healthcare system…

Michael Quirmbach – CEO & President, CordenPharma

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the…

Anil Okay – General Manager, Adalvo & Chief Commercial…

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach, and commercial strategy…

Top 20 Companies for Access to Medicine 2021

The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and development, and product delivery indices.…

EUnetHTA’s Uncertain Future & the Evolution of…

The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European…

Jean-Paul Clozel – CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

Tagged with